logo

VSEE

VSee Health·NASDAQ
--
--(--)
--
--(--)
0.36 / 10
Underperform

Fundamental scrutiny indicates poor standing (0.4/10). Favorable drivers: Interest coverage ratio (EBIT / Interest expense) (%) and Quick ratio, however risks emerge in Inventory turnover days and Total profit (YoY growth rate %). Investment outlook: selective.

Fundamental(0.36)SentimentTechnical

Analysis Checks(5/10)

Total operating revenue (YoY growth rate %)
Value59.90
Score3/3
Weight-62.97%
1M Return4.49%
Quick ratio
Value2.20
Score2/3
Weight-5.42%
1M Return0.56%
Total profit (YoY growth rate %)
Value87.81
Score1/3
Weight43.06%
1M Return-4.59%
Net cash flow from operating activities (YoY growth rate %)
Value46.02
Score0/3
Weight51.91%
1M Return-5.07%
Fixed assets turnover ratio
Value15.12
Score1/3
Weight33.37%
1M Return-3.59%
Long-term debt to working capital ratio (%)
Value27.19
Score2/3
Weight12.06%
1M Return-1.19%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight17.21%
1M Return-1.71%
Operating revenue (YoY growth rate %)
Value59.90
Score3/3
Weight-62.97%
1M Return4.49%
Net profit attributable to parent company shareholders (YoY growth rate %)
Value87.41
Score1/3
Weight45.68%
1M Return-5.11%
Inventory turnover days
Value232.28
Score1/3
Weight28.08%
1M Return-3.18%
Is VSEE undervalued or overvalued?
  • VSEE scores 0.36/10 on fundamentals and holds a Premium valuation at present. Backed by its 0.00% ROE, -69.81% net margin, -1.16 P/E ratio, -2.10 P/B ratio, and 106.75% earnings growth, these metrics solidify its Underperform investment rating.